This topic contains a solution. Click here to go to the answer

Author Question: What is the major adverse risk when administering an enteral supplemental feeding to a patient ... (Read 79 times)

nummyann

  • Hero Member
  • *****
  • Posts: 576
What is the major adverse risk when administering an enteral supplemental feeding to a patient through a feeding tube?
 
  a. Aspiration of tube feeding contents.
  b. Abdominal pain when given too fast.
  c. Toxicity from too many vitamins and minerals.
  d. Peritonitis if the bowel ruptures.

Question 2

A patient is receiving supplemental enteral
 
  feedings with Osmolite, 1 can three times a day between meals. For which main side effect should you monitor?
  a. Constipation
  b. Nausea
  c. Vomiting
  d. Diarrhea



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

Danny Ewald

  • Sr. Member
  • ****
  • Posts: 332
Answer to Question 1

ANS: A

Answer to Question 2

ANS: D




nummyann

  • Member
  • Posts: 576
Reply 2 on: Jul 23, 2018
:D TYSM


pangili4

  • Member
  • Posts: 346
Reply 3 on: Yesterday
Wow, this really help

 

Did you know?

The most destructive flu epidemic of all times in recorded history occurred in 1918, with approximately 20 million deaths worldwide.

Did you know?

The eye muscles are the most active muscles in the whole body. The external muscles that move the eyes are the strongest muscles in the human body for the job they have to do. They are 100 times more powerful than they need to be.

Did you know?

Oliver Wendell Holmes is credited with introducing the words "anesthesia" and "anesthetic" into the English language in 1846.

Did you know?

Pink eye is a term that refers to conjunctivitis, which is inflammation of the thin, clear membrane (conjunctiva) over the white part of the eye (sclera). It may be triggered by a virus, bacteria, or foreign body in the eye. Antibiotic eye drops alleviate bacterial conjunctivitis, and antihistamine allergy pills or eye drops help control allergic conjunctivitis symptoms.

Did you know?

Certain topical medications such as clotrimazole and betamethasone are not approved for use in children younger than 12 years of age. They must be used very cautiously, as directed by a doctor, to treat any child. Children have a much greater response to topical steroid medications.

For a complete list of videos, visit our video library